These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26471463)

  • 1. Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.
    Turnbull IC; Eltoukhy AA; Fish KM; Nonnenmacher M; Ishikawa K; Chen J; Hajjar RJ; Anderson DG; Costa KD
    Mol Ther; 2016 Feb; 24(1):66-75. PubMed ID: 26471463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents.
    Turnbull IC; Eltoukhy AA; Anderson DG; Costa KD
    Methods Mol Biol; 2017; 1521():153-166. PubMed ID: 27910047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.
    Huang CL; Leblond AL; Turner EC; Kumar AH; Martin K; Whelan D; O'Sullivan DM; Caplice NM
    Mol Pharm; 2015 Mar; 12(3):991-6. PubMed ID: 25588055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Modified mRNA in a Myocardial Infarction Mouse Model.
    Kaur K; Sultana N; Hadas Y; Magadum A; Sharkar MTK; Chepurko E; Zangi L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration.
    Labonia MCI; Estapé Senti M; van der Kraak PH; Brans MAD; Dokter I; Streef TJ; Smits AM; Deshantri AK; de Jager SCA; Schiffelers RM; Sluijter JPG; Vader P
    J Control Release; 2024 May; 369():734-745. PubMed ID: 38604385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Cardiac Delivery of Modified mRNA.
    Sultana N; Magadum A; Hadas Y; Kondrat J; Singh N; Youssef E; Calderon D; Chepurko E; Dubois N; Hajjar RJ; Zangi L
    Mol Ther; 2017 Jun; 25(6):1306-1315. PubMed ID: 28389322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.
    Sultana N; Sharkar MTK; Hadas Y; Chepurko E; Zangi L
    Methods Mol Biol; 2021; 2158():281-294. PubMed ID: 32857381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus.
    Kaspar BK; Roth DM; Lai NC; Drumm JD; Erickson DA; McKirnan MD; Hammond HK
    J Gene Med; 2005 Mar; 7(3):316-24. PubMed ID: 15515115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Strategy for Modified mRNA Inducing Cardiac-Specific Expression in Mice.
    Huang C; Jia J; Jin K; Zou Y; Tan S; Lu J; Zhu Y; Lin J; Dai Y; Gong H
    J Cardiovasc Transl Res; 2023 Oct; 16(5):1078-1084. PubMed ID: 37155138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
    Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified mRNA as a Treatment for Myocardial Infarction.
    Wang Y; Wu M; Guo H
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish.
    Patton C; Farr GH; An D; Martini PGV; Maves L
    Zebrafish; 2018 Jun; 15(3):217-227. PubMed ID: 29369745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Modified mRNA for Myocardial Delivery.
    Kondrat J; Sultana N; Zangi L
    Methods Mol Biol; 2017; 1521():127-138. PubMed ID: 27910045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium.
    Yuan QY; Zhu ZW; Wang Z; Wang XM; Li XS; Huang J; Si LY
    Heart Vessels; 2012 May; 27(3):316-26. PubMed ID: 21688013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
    Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
    J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.
    Lu ZX; Mao LL; Lian F; He J; Zhang WT; Dai CY; Xue S; Lu WG; Zhu HS
    BMC Cardiovasc Disord; 2014 Apr; 14():53. PubMed ID: 24742302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, and location of expression.
    Leor J; Quiñones MJ; Patterson M; Kedes L; Kloner RA
    J Mol Cell Cardiol; 1996 Oct; 28(10):2057-67. PubMed ID: 8930802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct reprogramming induces vascular regeneration post muscle ischemic injury.
    Kaur K; Hadas Y; Kurian AA; Żak MM; Yoo J; Mahmood A; Girard H; Komargodski R; Io T; Santini MP; Sultana N; Sharkar MTK; Magadum A; Fargnoli A; Yoon S; Chepurko E; Chepurko V; Eliyahu E; Pinto D; Lebeche D; Kovacic JC; Hajjar RJ; Rafii S; Zangi L
    Mol Ther; 2021 Oct; 29(10):3042-3058. PubMed ID: 34332145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.
    Zangi L; Lui KO; von Gise A; Ma Q; Ebina W; Ptaszek LM; Später D; Xu H; Tabebordbar M; Gorbatov R; Sena B; Nahrendorf M; Briscoe DM; Li RA; Wagers AJ; Rossi DJ; Pu WT; Chien KR
    Nat Biotechnol; 2013 Oct; 31(10):898-907. PubMed ID: 24013197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.